Kirk L. Clark

mx wwpdb

Novartis

Info

Structural biologist at Novartis (Novartis Institutes for BioMedical Research). Serves as the industrial structural biology representative on the wwPDB Scientific Advisory Committee, representing the pharma user community of the RCSB PDB.

wwPDB role

Advisory Committee member, RCSB PDB representative. Provides the pharmaceutical industry perspective on PDB use, deposition, and validation requirements. Industrial representation on the AC is important because pharma is among the largest user communities of the PDB for structure-based drug discovery.

Affiliations

• Novartis — structural biology

Committees & service

• wwPDB Advisory Committee — RCSB PDB (industry) representative

Sources

• wwPDB 2025 Advisory Committee report: https://cdn.rcsb.org/wwpdb/docs/about/advisory/wwpdbac2025-report.pdf